ExThera Medical

ExThera Medical’s extracorporeal products have demonstrated life-saving capabilities in a wide range of critically ill patients suffering from severe infections, and the potential to treat stage 4 metastatic cancer patients. Prior to a successful entrepreneurial career, Robert was Director of Research at Avco Medical Products and later spent a decade at Thoratec as President of the Biomaterials Division. Sallie received a Bachelor of Science in Industrial Technology, Product Design with a minor in Business Administration from San Francisco State University. Michael DiMeo, the company’s Chief Financial Officer, leverages over 25 years of experience in financial management and capital structuring of MedTech companies in life science, oncolytic and exosome diagnostics. Extensive track record in guiding excellence in product safety and development, focusing on achieving successful global product launches, developing strong relationships with regulatory authorities, building deep technical knowledge and talent bases, and implementing strategic process improvements. Career highlights include product marketing through notable acquisitions; Most recently Astute Medical and subsequent acquisition, and Gambro/Baxter International/Inc. Experience includes responsibility for product launches, early market development commercial growth, >$100M mature product portfolio management, and strategic development initiatives therein. With a focus on critical care and nephrology, Dr.